Chronic Coronary Artery Disease Management - Dr Cutlip.pdf

More documents

Recommendations

Info

Limitations of Routine Screening • 10-15% false positives and false negatives • Risk of angiography and revascularization procedures • Unproven benefit of treatment beyond risk factor control • Failure to prevent events over time – DIAD showed no difference in cardiac events among patients randomized to screening. 1 1. LH Young et al JAMA 2009;301:1547–1555
Screen Asymptomatic DM Patients? Updated ADA Recommendations • Typical or atypical symptoms • Abnormal resting ECG • Prior recommendation for screening of patients with 2 or more other CAD risk factors and prior to exercise program removed. Diabetes Care 2013;Suppl l:S32
Page 1 and 2: Cardiovascular Disease and Diabetes
Page 3 and 4: Prevalence Diabetes - A Cardiovascu
Page 5 and 6: Hallmarks of Diabetic Coronary Arte
Page 7 and 8: Diabetes and Coronary Thrombosis
Page 9: Screen Asymptomatic DM Patients?
Page 13 and 14: Step 1- Prevention Diabetes and Pat
Page 15 and 16: Why Does Intensive Glycemic Control
Page 17 and 18: BARI 2D - Glycemic Control Strategy
Page 19 and 20: Diabetes and Coronary Disease The R
Page 21 and 22: Role of Intensive Therapy What is t
Page 23 and 24: Targeting Diabetic Dyslipidemia Is
Page 25 and 26: Medical Therapy of CAD • Risk fac
Page 27 and 28: Medical Rx vs Revascularization Imp
Page 29 and 30: Medical Therapy versus CABG BARI-2D
Page 31 and 32: Ischemia Reduction in COURAGE Impac
Page 33 and 34: FAME II Trial N=888 randomized FFR
Page 35 and 36: Diabetic Patients With Multivessel
Page 37 and 38: FREEDOM Trial Design (2) Design: Su
Page 39 and 40: BARI RCT: Relationship between IMA
Page 41 and 42: Assessment and Treatment of CAD Pro
Page 43: Conclusions • CAD is prevalent am

Chronic Coronary Artery Disease Management - Dr Cutlip.pdf

Create successful ePaper yourself

Delete template?

Save as template?